Acuta Capital Partners, LLC Oric Pharmaceuticals, Inc. Transaction History
Acuta Capital Partners, LLC
- $92.9 Million
- Q2 2024
A detailed history of Acuta Capital Partners, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 96,000 shares of ORIC stock, worth $900,480. This represents 0.73% of its overall portfolio holdings.
Number of Shares
96,000
Previous 103,992
7.69%
Holding current value
$900,480
Previous $1.43 Million
52.55%
% of portfolio
0.73%
Previous 1.17%
Shares
2 transactions
Others Institutions Holding ORIC
# of Institutions
115Shares Held
63.2MCall Options Held
0Put Options Held
0-
Nextech Invest Ag5.29MShares$49.6 Million7.05% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$45.3 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$41.2 Million3.41% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$38.9 Million1.73% of portfolio
-
Viking Global Investors LP4MShares$37.5 Million0.11% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $371M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...